An email landed in our inbox this week from Peter Diamandis, one of the most followed voices in longevity and exponential technology. The argument in it is one we have been making in this newsletter for months. He was simply making it to a very different room.
Every cell you have runs on a molecule called ATP. Muscle contraction pulls from it. Thought pulls from it. DNA repair pulls from it. You move through roughly your own body weight in it over the course of a single day.
The structures that produce it are your mitochondria, and with age they take on damage. Membranes oxidize, output falls, and a cell that cannot generate enough energy stops repairing itself and begins to break down. Diamandis calls that a key driver of aging itself. We have been calling it something simpler. The body is not broken. It is depleted.
| ? | When you read that energy production declines with age, does it land as a fact of life, or as something you have quietly been accommodating for a while now? |
| ? | If the most advanced labs on earth are raising hundreds of millions to solve cellular energy, what does that tell you about how much of your day depends on it? |
| ? | How much of what you have been calling aging is actually depletion you have gotten used to? |
A company called Cellergy Therapeutics has developed a way to produce healthy mitochondria at volume from young human donor cells, then deliver them intravenously so they circulate, get taken up by cells throughout the body, and restore ATP production. In animal studies, the transplanted mitochondria reached tissue everywhere, including the brain.
Dr. Nir Barzilai of the Albert Einstein College of Medicine, one of the most respected aging researchers alive, chairs their scientific advisory board. He has called the approach "a game-changer."
Read that list again. Most of it is already on ours.
Here is the part worth pausing on. The therapy does not exist yet. Their lead candidate is only now moving toward first-in-human trials. The first patients will be children with congenital mitochondrial disorders. Adults, degenerative disease, and longevity come after that. Years after that.
|
Replace Them
Grown in a bioreactor from donor cells. Delivered by IV infusion. Requires donor matching, manufacturing at scale, and regulatory clearance. Available: not yet.
|
Recharge Them
Your own mitochondria, already in place. Restored through electromagnetic signal. Nothing added to the body, no needles, no donor. Available: this week, in Fort Lauderdale.
|
DEMP therapy does not hand you new mitochondria. It restores the cellular voltage the ones you already have need in order to work. A healthy cell holds a charge. A depleted cell does not. Bring the voltage back and ATP production comes back with it, and the cell returns to the repair work it was built to do.
We are not arguing against the science. What Cellergy is building is remarkable and we will be watching it closely. But there is something worth protecting while the labs catch up, which is your ability to charge your own body without waiting on a trial, a donor, or a prescription.
The future of longevity medicine may well involve donor cells, infusion clinics, and waiting lists. It is being built right now and it will help a great many people when it arrives.
The version available to you today requires a room, a bed, and the willingness to give your cells what they have been missing.
Book your next session and tell us what your energy has been like. We will build the protocol around it.